Skip to main content
. 2022 Mar 21;2(2):oeac019. doi: 10.1093/ehjopen/oeac019

Figure 5.

Figure 5

Stroke in P2Y12 inhibitor monotherapy versus aspirin monotherapy. The occurrence of stroke (ischemic/hemorrhagic) was reported in 7 trials. No significant difference was observed in the risk of stroke (RR 0.85 [95% CI 0.73–1.01], I2 = 43.3%). CI = confidence interval, P2Y12i = P2Y12 inhibitor, RR = risk ratio.